Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131749) titled 'A Prospective, Multicenter Study of Recombinant Human Thrombopoietin for Thrombocytopenia After Consolidation Chemotherapy in Children with Acute Leukemia' on Sept. 6.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Qilu Hospital of Shandong University
Condition:
Thrombocytopenia Induced by Chemotherapy for Acute Leukemia
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-11-07
Target Sample Size: Recombinant human thrombopoietin (rhTPO) treatment group:92;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html...